703 related articles for article (PubMed ID: 19249511)
1. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M
Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of fructose consumption on uric acid and plasma lipids in patients with impaired renal function.
Zawiasa A; Nowicki M
Metabolism; 2013 Oct; 62(10):1462-9. PubMed ID: 23866980
[TBL] [Abstract][Full Text] [Related]
3. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients.
Kanbay M; Akcay A; Huddam B; Usluogullari CA; Arat Z; Ozdemir FN; Haberal M
Transplant Proc; 2005 Sep; 37(7):3119-20. PubMed ID: 16213325
[TBL] [Abstract][Full Text] [Related]
4. Renal function and lipid metabolism in pregnant renal transplant recipients.
Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
[TBL] [Abstract][Full Text] [Related]
5. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
[TBL] [Abstract][Full Text] [Related]
6. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus.
Trotter JF; Wachs ME; Trouillot TE; Bak T; Kugelmas M; Kam I; Everson G
Liver Transpl; 2001 May; 7(5):401-8. PubMed ID: 11349259
[TBL] [Abstract][Full Text] [Related]
7. New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?
Deleuze S; Garrigue V; Delmas S; Chong G; Swarcz I; Cristol JP; Mourad G
Transplant Proc; 2006 Sep; 38(7):2311-3. PubMed ID: 16980075
[TBL] [Abstract][Full Text] [Related]
8. Similar lipid profile but improved long-term outcomes with sirolimus after cyclosporine withdrawal compared to sirolimus with continuous cyclosporine.
Morales JM; Hartmann A; Walker R; Arns W; Senatorski G; Grinyó JM; Shoker A; Wilczek H; Jamieson NV; Lelong M; Brault Y; Burke JT; Scarola JA;
Transplant Proc; 2009; 41(6):2339-44. PubMed ID: 19715914
[TBL] [Abstract][Full Text] [Related]
9. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
Yu X; Zhang B; Xing C; Sun B; Liu M; Zhang W; Gu M
Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
[TBL] [Abstract][Full Text] [Related]
10. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
Chang HR; Lin CC; Lian JD
Transplant Proc; 2007 Dec; 39(10):3135-41. PubMed ID: 18089339
[TBL] [Abstract][Full Text] [Related]
11. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens.
Law YM; Yim R; Agatisa P; Boyle GJ; Miller SA; Lawrence K; Webber SA
J Heart Lung Transplant; 2006 Mar; 25(3):276-82. PubMed ID: 16507419
[TBL] [Abstract][Full Text] [Related]
12. Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study.
Marcén R; Chahin J; Alarcón A; Bravo J
Transplant Proc; 2006 Oct; 38(8):2427-30. PubMed ID: 17097957
[TBL] [Abstract][Full Text] [Related]
13. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
[TBL] [Abstract][Full Text] [Related]
14. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus.
Bakar F; Keven K; Dogru B; Aktan F; Erturk S; Tuzuner A; Erbay B; Nebioglu S
Transplant Proc; 2009 Jun; 41(5):1630-3. PubMed ID: 19545695
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus, cyclosporine and plasma lipoproteins in renal transplant recipients.
Venkiteswaran K; Sgoutas DS; Santanam N; Neylan JF
Transpl Int; 2001 Dec; 14(6):405-10. PubMed ID: 11793038
[TBL] [Abstract][Full Text] [Related]
17. Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients.
Pohanka E; Margreiter R; Sparacino V; Sperschneider H;
Transplant Proc; 2005 May; 37(4):1874-6. PubMed ID: 15919490
[TBL] [Abstract][Full Text] [Related]
18. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy.
Videla CO
Transplant Proc; 2009; 41(6):2659-63. PubMed ID: 19715995
[TBL] [Abstract][Full Text] [Related]
19. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
Chamienia A; Biedunkiewicz B; Król E; Debska-Slizień A; Rutkowski B
Transplant Proc; 2006; 38(1):81-5. PubMed ID: 16504670
[TBL] [Abstract][Full Text] [Related]
20. Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients.
Hohage H; Arlt M; Brückner D; Dietl KH; Zidek W; Spieker C
Clin Transplant; 1997 Jun; 11(3):225-30. PubMed ID: 9193847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
